Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 18, 2005American Journal of Respiratory and Critical Care MedicineOpen Access

Acquired Rifamycin Resistance with Twice-Weekly Treatment of HIV-related Tuberculosis

View Full Paper
Ask AI
Bookmark
Share

Authors

WBWilliam J. BurmanDenver Health Medical CenterDBDebra BenatorGeorge Washington UniversityAVAndrew VernonCenters for Disease Control and Prevention

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Burman et al. (2005) studied this question.

synapsesocial.com/papers/6a106ac1e1a472cb5efcdcfahttps://doi.org/10.1164/rccm.200503-417oc
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Treatment of Tuberculosis in Patients with Advanced Human Immunodeficiency Virus Infection1991 · 481 citations
  2. 2Efficacy and Safety of Rifabutin in the Treatment of Patients With Newly Diagnosed Pulmonary Tuberculosis1996 · 101 citations
  3. 3The Effect of Directly Observed Therapy on the Rates of Drug Resistance and Relapse in Tuberculosis1994 · 598 citations
  4. 4Risk Factors for Relapse and Acquired Rifamycin Resistance after Directly Observed Tuberculosis Treatment: A Comparison by HIV Serostatus and Rifamycin Use2004 · 83 citations